Establishing the etiology of invasive fungal infections is important to guide therapeutic options and for epidemiologic purposes. Formalin-fixed, paraffin-embedded (FFPE) tissue specimens from patients with proven invasive fungal infections are valuable to determine the etiology of systemic fungal infections. We compared different polymerase chain reaction (PCR) amplification strategies from FFPE tissue blocks to identify agents of invasive fungal infections. We found that specific PCR assays show superior sensitivity in the identification of DNA of Mucorales and Aspergillus and mixed infections caused by both as compared to broad-range PCR assays. Shorter amplicon lengths and less detection of contaminating fungal DNA are potential factors involved. However, detection of fungal DNA by highly sensitive specific PCR assays in the absence of demonstration of fungal elements in tissue suggests that PCR results should be interpreted in the context of the histopathology and clinical findings.
Introduction
Although candidiasis, aspergillosis, and cryptococcosis are the most prevalent systemic fungal infections, mucormycosis, fusariosis, and others gain more relevance in immunocompromised hosts, as they require specific management strategies due to intrinsic in vitro resistance to antifungals.
In clinical practice, many fungal infections are managed without mycological confirmation of the causative agents, but establishing the fungal etiology is particularly important to guide empiric therapy choices, in the management of refractory infections and for epidemiologic purposes.
Formalin-fixed, paraffin-embedded (FFPE) tissue specimens from patients with proven invasive fungal infections are valuable to determine the etiology of systemic fungal infections. The identification of fungi by morphology of fungal elements in tissue is limited to a few fungal groups. Therefore, the identification of fungi from FFPE tissue blocks by molecular tools, including polymerase chain reaction (PCR) and sequencing has increasingly gained attention, as causative agents may be identified to the species level. However, amplification of DNA from agents of invasive fungal infections from FFPE samples has been challenging with broad-range PCR positivity in 15-90% of samples. 1 Determinants for positive fungal PCR from FFPE samples may include efficient DNA extraction, the absence of PCR inhibition, the use of buffered formalin, and short periods in fixatives before fungal DNA extraction, and the prevention of DNA contamination of chemicals used and during the extraction procedure. 1 In addition, the PCR step also seems to be of critical importance, but studies comparing different PCR amplification strategies including broad-range or specific PCRs targeting frequent agents of invasive infections are limited.
We compared different broad-range PCR assays targeting the 28S ribosomal RNA genes that have been previously reported for the sensitive and specific amplification of fungal DNA in the presence of human DNA with specific PCR assays targeting the ribosomal RNA genes of Aspergillus and the Mucorales, the two most frequently encountered agents of mould infections in immunocompromised hosts. We found that specific PCR assays are superior in the identification of DNA of Mucorales and Aspergillus and mixed infections caused by both as compared to broad-range PCR assays.
Methods

Formalin-fixed, paraffin-embedded tissue samples
We included FFPE tissue samples from patients with suspected invasive fungal infection based on radiologic and clinical findings including unresponsiveness to antibacterial therapies. The samples were sent for fungal identification to the reference laboratory for cryptococcosis and rare systemic fungal infections at the Robert Koch-Institute in Berlin, Germany. Culture results and clinical data were not available for these samples. Blocks were cut using a microtome with fresh blades for each sample. The first and last cuts were stained using Grocott´s methenamine silver stain (GMS) to verify the presence of fungal elements in the tissue. Aliquots of four cuts (5 μm each) were placed in DNA free tubes and stored at room temperature until DNA extraction. Depending on the morphology of fungal elements in the tissue, the samples were classified as either free from fungal elements (n = 22) or provided evidence for hyalohyphomycosis (n = 18), yeast infection (n = 4) or mucormycosis (n = 2) as described previously. 2 Morphology was classified without prior knowledge of clinical and molecular data by two researchers (I.M.S., D.W.). Samples with conflicting results between microscopy and PCR were reviewed again to resolve conflicts (I.M.S., D.W., V.R.). The study was approved by the institutional review board of the Goethe-University Hospital in Frankfurt, Germany (track number 375/10).
DNA extraction
All steps for extracting DNA from FFPE samples were performed in a class II laminar-flow cabinet. Briefly, four sections of 5 μm were deparaffinized using xylene. 3 After short air drying, the Amplicons of positive Mucorales PCR assays were sequenced (see below). Two broad-range fungal PCR assays targeting 340 (primer 10f-12r) or 200 (primer 12f-13r) base pair regions of the 28S rRNA gene were used to amplify fungal DNA. 8 Briefly, 10 μl iTaq Universal SYBR Green Supermix (Bio-Rad, Hercules, CA, USA) and 0.4 μM each of forward and reverse primers were used in a total volume of 20 μl with 5 μl of template DNA and tested in a StepOnePlus machine with the following steps: 95
• C for 5 min, followed by 45 cycles of 95
• C for 15 s, 55
• C for 30 s, and 72
• C for 30 s. Amplicons were purified and sequenced 7 .
Sequences were identified through BLAST search with the Genbank database (National Center of Biotechnology Information, Washington DC; www.ncbi.nlm.nih.gov/BLAST). Coverage and homology had to reach at least 98%. Samples below this homology threshold were declared negative (n = 4).
All fungal PCR assays were performed in duplicate and a single positive PCR replicate was sufficient as a positive result. Controls included in each run consisted of negative, that is, no template, negative extraction controls, and positive PCR controls consisting of genomic DNA from Aspergillus fumigatus and Lichtheimia corymbifera. The sensitivity of the PCR assays was evaluated with BAL samples spiked with 1, 10, and 100 cfu/ml of Candida parapsilosis yeast cells, and conidia of Aspergillus fumigatus or Rhizopus oryzae. While the specific assays detected 10 cfu/ml of the respective mould only, both broad-range PCR assays detected DNA of the three fungi at 10 cfu/ml. All PCR tests were analyzed blinded to histopathologic results.
Human DNA was quantified targeting the 18S rRNA gene. 9 Briefly, PCR was performed in 20 μl using 10 μl of TaqMan gene expression master mix, and 2 μl of template DNA. The amounts of primers and probe were reduced to 400 nM and 90 nM, respectively. Elongation temperature was decreased to 60
An internal amplification control assay, consisting of Bacillus DNA was detected independently of the fungal target (monoplex) but within the same PCR run. The reaction mixtures (20 μl in total) contained primers and probe as described before. 4 Besides the use as extraction control, Bacillus DNA was also used to monitor PCR inhibition. For this, 1000 plasmid copies of Bacillus DNA were spiked in every PCR reaction. PCR inhibition was claimed if the sample Cq value differed more than 3.3 from the controls.
Statistics
Identification of fungal DNA in FFPE tissue samples containing mould hyphae by specific and broad-range PCR assays was compared by Fisher exact test using Graphpad Quickcalcs (https://www.graphpad.com/quickcalcs/). A two-sided test < 0.05 was considered significant.
Results
Human DNA was detected in 38 of 46 samples (83%). Evidence for inhibition of the PCR reaction was found in 11 samples (24%) showing hyalohyphomycetes (n = 2) or no fungi (n = 9). However, human DNA was detected in 9 of 11 samples showing inhibition and specific fungal PCRs detected fungal DNA in 3 of 11 samples (Aspergillus, n = 2; Rhizopus, n = 1) but none of the broad-range assays ( Table 1) . The PCR assay specific for Aspergillus detected DNA in 17 of 18 samples (94%) showing hyphae suggestive for hyalohyphomycosis, confirming aspergillosis as the most prevalent hyalohyphomycosis in these samples. The PCR specific for Mucorales amplified DNA from Mucorales in both samples with histopathologic evidence for mucormycosis (100%). In addition, this assay amplified DNA in two samples diagnosed as hyalohyphomycosis together with Aspergillus DNA by the Aspergillus specific PCR, suggesting a mixed infection not identified by initial microscopic examination but confirmed by repeated microscopy after molecular results (Fig. 1) . Sequencing of the amplicons of the Mucorales PCR identified DNA of Rhizopus in these samples.
The Aspergillus PCR assays amplified DNA from 3 of 26 samples (12%) without mould hyphae, that is, samples without detection of mould or yeast by microscopy. The Mucorales PCR amplified DNA from 1 of these 26 samples (4%). A repeated microscopic review confirmed the absence of mould hyphae in these samples. As both specific PCRs did not amplify fungal DNA from no template controls and extraction negative controls, this suggested the presence of fungal DNA within the FFPE samples that are not due to invasive infection.
Also verified was the presence of hyphae suggestive for hyalohyphomycosis in one sample with negative specific PCRs. As broad-range PCR was negative, a failure to amplify mould DNA from this sample was assumed.
The broad-range assay amplifying a longer amplicon (10f-12r) identified Aspergillus DNA in 10 and DNA of Mucorales, that is, Rhizopus, in 1 of 20 (55%) samples showing mould infection. In addition, DNAs of Candida (n = 1) and Cladosporium (n = 1) were detected. In three samples with mould hyphae, different amplicons were amplified, and sequencing showed mixed infections that could not be identified.
The broad-range assay amplifying a shorter amplicon (12f-13r) identified Aspergillus DNA in 13 and DNA of Mucorales, that is, Rhizopus, in 1 of 20 samples showing mould hyphae (70%). In addition, DNA of Candida (n = 1) was detected.
The 10f-12r assay identified Candida DNA from two of four (50%) and the 12f-13r assay in one of four (25%) samples from yeast infections.
Both broad-range PCR assays amplified fungal DNA from elution buffer, no template-and extraction negative controls. Negative extraction controls (n = 4), negative PCR controls (DNA-free water; n = 6), and pure elution buffer tested in the broad-range PCR assays (n = 14) showed 17% (n = 4) and 21% (n = 5) positives in the 10f -12r and the 12f-13r assays, respectively. Sequencing revealed Malassezia sp., for the 10f -12r assay in all positive control samples (100%), but Gigaspora sp. (60%), Paecilomyces sp. (20%), and Aspergillus sp. (20%) for the 12f -13r assay, respectively.
In FFPE samples without fungal elements, the 10f-12r assay identified DNA in seven samples (32%) and the 12f-13r assay identified DNA in seven samples (32%). Sequencing revealed organisms already identified from negative controls and additionally common airborne fungi including Penicillium and Alternaria but not Aspergillus or Mucorales as the specific assays in some cases. In addition, mixed fungal DNA amplicons were amplified from 10f-12r assay (n = 7) and from the 12f-13r assay (n = 4).
In conclusion, the broad-range PCR assays identified DNA of Aspergillus or Mucorales less often in samples showing mould hyphae than the combination of the specific Aspergillus and Mucorales assays. In contrast to the specific assays, broad-range assays did not detect cases of mixed aspergillosis and mucormycosis but identified additional fungal pathogens ( Table 2) .
Discussion
As the identification of fungi by the morphology of fungal elements in tissue specimens is limited to a few fungal groups, fungal identification from FFPE tissue blocks by PCR and sequencing has increasingly gained attention in samples without culture confirmation of causative fungal agents. Causative agents may be identified in culture negative samples to the genus or species level, improving our knowledge on the etiology of systemic fungal infections, allowing for improved preventive and therapeutic measures. We compared different strategies to amplify fungal DNA from FFPE tissue samples of patients with suspected invasive fungal infection. Several insights were gained by the inclusion of samples representing common fungal infections including aspergillosis and mucormycosis, samples without fungal elements, controls for critical procedural steps, and different PCR amplification strategies.
First, specific PCR assays targeting Aspergillus and Mucorales are superior in the identification of DNA from these common agents of mould infections from FFPE tissue specimens as compared to broad-range PCR assays. This has been suggested previously by Buitrago et al. using a panel of specific PCR assays and a broad-range assay. However, as not all samples in their study were analyzed by both approaches, this study is limited in this respect. 10 Potential reasons for the superior sensitivity of specific PCR assays include a shorter amplicon length when compared to the broad-range assays used in this study, allowing for a superior amplification of target DNA from FFPE tissue that may contain crosslinked DNA due to the fixation with formalin. In addition, broad-range assays may be prone to preferential amplification of one amplicon when different amplicons are present in a sample due to different amounts of DNA or primer mismatches with one amplicon. The relevance of mixed fungal infections caused by different fungi is difficult to assess. While previous reports documented mixed infections in 3-5% of tissue samples from autopsy cases by microscopy, the use of specific PCR assays does not always support the presence of different fungi when this is suspected by hyphal morphology detected by microscopy, as hyphal elements of fungi can vary substantially in tissue samples in respect to septation, width and other morphologic aspects used for classification. 11, 12 Second, our comparison of two different broad-range PCR sets suggests different sensitivities for identification of fungal DNA from FFPE samples. As described previously, this may be caused by different amplicon lengths. 13, 14 In addition, broadrange PCR assays differ in the range of fungal agents detected. While the assays used in our study differ in amplicon length, they also differ in the number of fungi they detect with good sensitivity. 8 Procedural false positives on the other hand may be caused by contaminating DNA in extraction kits or fungal DNA introduced during processing of the specimens, during fixation and preparation of cuts, and subsequently during the extraction procedure. As would be expected, compared with specific PCR assays, broad-range PCR assays in our study were more likely to amplify contaminating fungal DNA representing typical skin flora and ubiquitous airborne fungi. Adequate controls are necessary to identify potential sources of contaminating DNA. Of note, our comparison of two broad-range PCR assays suggests that broad-range assays may not be equally prone to amplification of contaminating DNA. The 10f-12r assay used in our study amplified fungal DNA more often from samples not containing fungal elements as detected by histopathology more frequently to identification of contaminating fungi or mixed fungal sequences. One potential reason may be that this assay has been shown to amplify DNA of a broader spectrum of fungi as compared to the 12f-13r assay. 8 Third, inhibition of PCR reactions as detected by an internal amplification control is frequent in FFPE tissue samples. We found inhibition in 24% of samples, in line with previous reports describing it in 5-50% of FFPE samples. Differences are potentially influenced by the extraction methods used. 2, 13 Of note, while we were able to amplify DNA of Aspergillus and the Mucorales with the specific PCR assays despite an internal amplification control demonstrating inhibition, amplification was mostly unsuccessful with the broad-range assays. However, underlying mechanisms are poorly understood.
In conclusion, the identification of common causative agents of mould infections, such as Aspergillus and the Mucorales from FFPE tissue samples by PCR and sequencing offers the potential for better fungal identification as compared to histopathology alone in cases without culture confirmation. Specific PCR assays targeting short ribosomal gene targets of common moulds show increased sensitivity as compared with broad-range PCR assays with longer amplicons identified by sequencing. However, for optimal results, a combination of specific and broad-range assays as well as control assays to monitor for inhibition and controls to identify contamination are required. In addition, molecular results should be evaluated in the context of histopathology results and clinical data.
